Back to
Duquesne Family Office LLC
RLAY
2 quarters
Position history for
Duquesne Family Office LLC's holdings in Relay Therapeutics, Inc.
Yes. Duquesne Family Office holds 852,600 shares of RLAY (Relay Therapeutics), worth $15.4M, as of its Q3 2026 13F filing. It increased the position by 503,600 shares (+144.3%) from Q2 2026. Duquesne Family Office has held RLAY since Q2 2026, across 2 quarterly 13F filings. RLAY is 0.3% of Duquesne Family Office's reported 13F portfolio.
Current Value
$15.4M
Current Shares
852,600
Total Value Change
+$8.9M
Total Shares Change
+503,600
Quarter-by-Quarter History
Other major holders of RLAY: SB Investment Advisers (UK) Ltd.